Eli Lilly and Company Add us as a preferred source on Google
Auto-generated from Eli Lilly and Company’s publicly available X info.
Eli Lilly and Company hasn’t claimed, verified, or endorsed it, and is not affiliated with, sponsored by, or a partner of SocialDB. Any rates shown are estimates, not set by the creator.
Known for
47.2K views
Protect your health: retatrutide is being studied in clinical trials and hasn’t been approved for sale to consumers. You don’t know what’s in black-market unapproved “reta.” Don’t take the risk. Learn more: https://t.co/xxCKielaDj
41.6K views
Adults with type 2 diabetes on our investigational triple agonist saw significant A1C reductions at 40 weeks in the TRANSCEND-T2D-1 trial. Results presented today at #ADA2026 and published simultaneously in @TheLancet. Read more: https://t.co/1Wx2P7saq2
10.5K views
New data: Our oral GLP-1 delivered superior A1C control and weight loss across three clinical trials. Read more: https://t.co/GuyV2Jv4iE #ADA2026
8.4K views
In a late-breaking oral presentation, Lilly shared Phase 3 study results for one of our medicines as part of a time-limited regimen in chronic lymphocytic leukemia (#CLL).
Learn more here: https://t.co/tIp1skLgXe
📊 Post performance
🔥 Top post: Protect your health: retatrutide is being studied in clinical tr · 47.2K views
📊 Activity & format
Recent posts
View on X ↗
🔥 Top post
Protect your health: retatrutide is being studied in clinical trials and hasn’t been approved for sale to consumers. You don’t know what’s in black-market unapproved “reta.” Don’t take the risk. Learn more: https://t.co/xxCKielaDj
Lilly’s injectable weight management medicine was linked to lower healthcare costs over time compared to those not on treatment. Read more from this new study: https://t.co/89ogjfCqfL
Helping more patients, growing our business, advancing our innovative pipeline, expanding for the future – our second quarter results continued to build momentum in a strong 2026. Read more: https://t.co/olKPDyRiSK
A Breakthrough Therapy designation granted by the @FDA will help advance a potential treatment option that could be meaningful for previously treated patients with a certain form of advanced #pancreaticcancer.
Learn more: https://t.co/nNU…
Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist.
Learn more: https://t.co/YZ6AWs9FqL
▶
Innovation is redefining what’s possible in retinal disease, and we’re working every day to advance progress in ophthalmology research to help people living with wet age-related macular degeneration.
Emerging research could offer a new approach to treatment-resistant depression. Read more on our agreement to acquire AtaiBeckley, a clinical-stage company developing innovative medicines for mental health conditions. https://t.co/vzLMH0d9…
A new pathway for access to obesity treatment through Medicare begins July 1. Eligible Medicare Part D patients may be able to get certain medicines for weight management through Medicare GLP-1 Bridge.
Learn more and see the CMS Medicare…
In a late-breaking oral presentation, Lilly shared Phase 3 study results for one of our medicines as part of a time-limited regimen in chronic lymphocytic leukemia (#CLL).
Learn more here: https://t.co/tIp1skLgXe
In an oral presentation at #EHA2026, initial clinical results will be shared from a Phase 1 study evaluating a first-in-class therapy in previously treated myelofibrosis.
Learn more here: https://t.co/3ylZ3ZWTrr
The @US_FDA has approved a new dosing option for Lilly’s moderate-to-severe atopic dermatitis (#eczema) treatment. Learn more about what this may mean for patients: https://t.co/JHc16JSo5u
💡 Facts
🕵️ Fake follower check
Estimated- Est. 66% real, active audience · Medium fake-follower risk.
- Low engagement (~3.4% of followers engage each post) — a sign of an inflated or inactive audience.
- Organic base — far more followers than accounts it follows.
- Established account (16+ years old).
- 0.04% engagement — below the ~2.2% typical for this size.
Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.
About
📸 Gallery
🔀 Audience overlap
EstimatedEstimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.
Voicemod
16%
DWF Labs
15%
Michigan Athletics 〽️
15%
Aragon.eth 🦅
11%
City of Los Angeles
11%
ENCE
10%
More like this
Find more →Frequently asked questions
How much does Eli Lilly and Company charge for a sponsorship?
How do I contact Eli Lilly and Company for a brand deal or collaboration?
How many followers does Eli Lilly and Company have?
✉ Message Eli Lilly and Company
Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.
- ✓ Message any influencer from their listing
- ✓ The influencer gets notified by email
- ✓ Manage every conversation in one inbox
Already Pro? Log in.
🎤 Event / appearance with Eli Lilly and Company
Booking an event / appearance is a Pro feature. Upgrade to book Eli Lilly and Company for an in-person or virtual appearance — payment held safely in escrow until the event is done.
- ✓ Book them for events, livestreams, panels & more
- ✓ Eli Lilly and Company gets notified by email
- ✓ Fee held in escrow, released after the appearance
Already Pro? Log in.
Eli Lilly and Company isn't on SocialDB yet
Eli Lilly and Company hasn't claimed this listing yet, so they can't accept sponsorships, collabs or other deals here. The prices shown are estimates.
You're out of free requests this month
Free accounts get 5 per month. Go Pro for unlimited sponsor pitches, collab requests & sponsorship deals — plus featured placement, the Verified badge, free withdrawals and more.
Upgrade to Pro — $9.95/mo →Your free limit resets on the 1st of next month.